Literature DB >> 1481927

Medullary pathway of the Bezold-Jarisch reflex in the rat.

A J Verberne1, P G Guyenet.   

Abstract

The central pathway mediating the Bezold-Jarisch reflex elicited by jugular vein injection of serotonin (5-HT) and phenyl biguanide (PBG) was studied in halothane-anesthetized, paralyzed rats. 5-HT and PBG produced hypotension and inhibition of lumbar sympathetic discharge often preceded by sympathoexcitation. The Bezold-Jarish reflex was blocked by bilateral kynurenic acid (KYN; glutamate antagonist, 1.25 nmol/side) microinjection into the solitary tract nucleus. Bilateral KYN injection into the caudal ventrolateral medulla (5 nmol/side) also blocked the reflex. Bilateral injection of bicuculline methiodide (BIC; 100 pmol/side) into the rostral ventrolateral medulla (RVL) reduced the depressor and sympathoinhibitory components of the reflex and enhanced an excitatory component. Blockade or attenuation of the Bezold-Jarisch reflex was always associated with a concomitant blockade or attenuation of the arterial baroreflex. RVL barosensitive neurons (n = 61) were inhibited (> 60% reduction in firing) by PBG and 5-HT. Iontophoretic application of BIC (n = 11 cells), but not strychnine (glycine antagonist), blocked inhibition of RVL neurons by 5-HT and PBG. The sympathoinhibitory component of the Bezold-Jarisch reflex may use a central pathway similar to that of the arterial baroreflex.

Entities:  

Mesh:

Year:  1992        PMID: 1481927     DOI: 10.1152/ajpregu.1992.263.6.R1195

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  26 in total

1.  In vivo modulation of vagal-identified dorsal medullary neurones by activation of different 5-Hydroxytryptamine(2) receptors in rats.

Authors:  C Sévoz-Couche; K M Spyer; D Jordan
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Major Autonomic Neuroregulatory Pathways Underlying Short- and Long-Term Control of Cardiovascular Function.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

3.  Non-NMDA receptors transmit cardiopulmonary C fibre input in nucleus tractus solitarii in rats.

Authors:  C G Wilson; Z Zhang; A C Bonham
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

4.  Glutamatergic inputs to the CVLM independent of the NTS promote tonic inhibition of sympathetic vasomotor tone in rats.

Authors:  Daniel A Mandel; Ann M Schreihofer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

5.  Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats.

Authors:  Domitila A Huber; Ann M Schreihofer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

6.  Activation of NTS A(1) adenosine receptors inhibits regional sympathetic responses evoked by activation of cardiopulmonary chemoreflex.

Authors:  Tomoko K Ichinose; Zeljka Minic; Cailian Li; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-18       Impact factor: 3.619

7.  Nucleus tractus solitarii A(2a) adenosine receptors inhibit cardiopulmonary chemoreflex control of sympathetic outputs.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Auton Neurosci       Date:  2013-10-25       Impact factor: 3.145

8.  Roles of arterial baroreceptor reflex during bezold-jarisch reflex.

Authors:  Koji Kashihara
Journal:  Curr Cardiol Rev       Date:  2009-11

9.  Development of attenuated baroreflexes in obese Zucker rats coincides with impaired activation of nucleus tractus solitarius.

Authors:  Priscila S Guimaraes; Domitila A Huber; Maria J Campagnole-Santos; Ann M Schreihofer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-26       Impact factor: 3.619

10.  Roles for CCK1 and 5-HT3 receptors in the effects of CCK on presympathetic vasomotor neuronal discharge in the rat.

Authors:  Mitsuhiko Saita; Anthony J M Verberne
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.